| 000 | 01760 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516042501.0 | ||
| 264 | 0 | _c20120123 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1439-0507 | ||
| 024 | 7 |
_a10.1111/j.1439-0507.2011.02045.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCornely, Oliver A | |
| 245 | 0 | 0 |
_aEfficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant disease. _h[electronic resource] |
| 260 |
_bMycoses _cNov 2011 |
||
| 300 |
_ae838-47 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAmphotericin B _xadministration & dosage |
| 650 | 0 | 4 |
_aAntifungal Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCandidiasis _xdrug therapy |
| 650 | 0 | 4 | _aCaspofungin |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aEchinocandins _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aLipopeptides _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicafungin |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xcomplications |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMarty, Francisco M | |
| 700 | 1 | _aStucker, Flavie | |
| 700 | 1 | _aPappas, Peter G | |
| 700 | 1 | _aUllmann, Andrew J | |
| 773 | 0 |
_tMycoses _gvol. 54 _gno. 6 _gp. e838-47 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1439-0507.2011.02045.x _zAvailable from publisher's website |
| 999 |
_c20923770 _d20923770 |
||